Prescription drug · NDA
Albenza (Albendazole) NDC 64896-693
Albendazole 200 mg/1 · Tablet, Film coated · Oral · Amneal Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64896-693-49 | 64896069349 | 2 TABLET, FILM COATED in 1 BOTTLE (64896-693-49)Marketed from Jun 11, 1996 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Albenza
- Generic name (nonproprietary)
- albendazole
- Active ingredients
- Albendazole — 200 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals LLCNDC labeler code 64896
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020666
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A Inducers (Mechanism)
- Identifiers
- Product ID 64896-693_6163d9cc-fcc2-40a8-9b3d-0cce16b99b27SPL ID 6163d9cc-fcc2-40a8-9b3d-0cce16b99b27SPL set ID 1977a867-0ee1-44c0-8da3-fe59c48699f5RxCUI 199672, 211148UNII F4216019LNUPC 0364896693495
- Pharmacologic class
- Anthelmintic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464896069349followed by a unit qualifier and the quantityPackage 64896-0693-49. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ALBENZA is an anthelmintic drug indicated for: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . ( 1.1 ) Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus . ( 1.2 ) 1.1 Neurocysticercosis ALBENZA is indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . 1.2 Hydatid Disease ALBENZA is indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granu…
Excerpt only. Read the full label for complete information.
About NDC 64896-693
- What is NDC 64896-693?
- 64896-693 is the product NDC for Albenza (albendazole), Albendazole 200 mg/1 tablet, film coated, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Albenza (Albendazole).
- What is the active ingredient?
- Albendazole.
- Who is the labeler?
- Amneal Pharmaceuticals LLC, NDC labeler code 64896. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Albenza?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 020666
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Albendazole | Albendazole 200 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals of New York LLC | 0115-1701 |